A year after Covid-19 was declared a global pandemic, and the world’s pharmaceutical companies threw themselves into the race to find a vaccine against the deadly disease, the contest is now on patenting their immunisation shots. But intellectual property rights drive prices and can discriminate against vaccine access, prompting louder and louder calls for patents to be temporarily waived.
from https://ift.tt/3ahCZ6I
Sem comentários:
Enviar um comentário